| 000 | 01872 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517231714.0 | ||
| 264 | 0 | _c20190527 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1879-355X | ||
| 024 | 7 |
_a10.1016/j.ijrobp.2018.07.2005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMusunuru, Hima Bindu | |
| 245 | 0 | 0 |
_aPhase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _c12 2018 |
||
| 300 |
_a1438-1447 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 | _aEndpoint Determination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphatic Irradiation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xradiotherapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aRadiosurgery _xadverse effects |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aD'Alimonte, Laura | |
| 700 | 1 | _aDavidson, Melanie | |
| 700 | 1 | _aHo, Ling | |
| 700 | 1 | _aCheung, Patrick | |
| 700 | 1 | _aVesprini, Daniel | |
| 700 | 1 | _aLiu, Stanley | |
| 700 | 1 | _aChu, William | |
| 700 | 1 | _aChung, Hans | |
| 700 | 1 | _aRavi, Ananth | |
| 700 | 1 | _aDeabreu, Andrea | |
| 700 | 1 | _aZhang, Liying | |
| 700 | 1 | _aCommisso, Kristina | |
| 700 | 1 | _aLoblaw, Andrew | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 102 _gno. 5 _gp. 1438-1447 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijrobp.2018.07.2005 _zAvailable from publisher's website |
| 999 |
_c28694247 _d28694247 |
||